LeMaitre Vascular, Inc. LMAT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 269.36M | 262.43M | 256.28M | 249.60M | 240.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 269.36M | 262.43M | 256.28M | 249.60M | 240.87M |
| Cost of Revenue | 78.00M | 71.13M | 70.77M | 71.06M | 69.93M |
| Gross Profit | 191.36M | 191.31M | 185.52M | 178.54M | 170.94M |
| SG&A Expenses | 102.89M | 98.58M | 98.35M | 96.49M | 94.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 198.06M | 185.11M | 183.22M | 181.69M | 178.93M |
| Operating Income | 71.30M | 77.32M | 73.06M | 67.91M | 61.93M |
| Income Before Tax | 81.84M | 84.73M | 80.62M | 75.18M | 68.91M |
| Income Tax Expenses | 18.50M | 19.06M | 18.21M | 17.45M | 15.57M |
| Earnings from Continuing Operations | 63.34 | 65.67 | 62.40 | 57.73 | 53.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.34M | 65.67M | 62.40M | 57.73M | 53.34M |
| EBIT | 71.30M | 77.32M | 73.06M | 67.91M | 61.93M |
| EBITDA | 82.08M | 87.82M | 83.55M | 78.33M | 72.16M |
| EPS Basic | 2.78 | 2.89 | 2.75 | 2.55 | 2.36 |
| Normalized Basic EPS | 2.16 | 2.34 | 2.23 | 2.09 | 1.91 |
| EPS Diluted | 2.75 | 2.85 | 2.71 | 2.51 | 2.31 |
| Normalized Diluted EPS | 2.11 | 2.24 | 2.17 | 2.03 | 1.84 |
| Average Basic Shares Outstanding | 91.24M | 91.03M | 90.78M | 90.55M | 90.35M |
| Average Diluted Shares Outstanding | 93.60M | 94.92M | 93.28M | 93.15M | 93.09M |
| Dividend Per Share | 0.95 | 0.90 | 0.85 | 0.80 | 0.76 |
| Payout Ratio | 34.23% | 31.21% | 30.93% | 31.37% | 32.20% |